Home / Business and Economy / Tenet Healthcare Soars on Cantor Fitzgerald Upgrade
Tenet Healthcare Soars on Cantor Fitzgerald Upgrade
3 Jul
Summary
- Cantor Fitzgerald reiterated its Overweight rating with a $245.00 price target.
- Improving patient acuity is a positive sign for Tenet Healthcare.
- Tenet's stock is trading 16.3% below its 52-week high of $244.80.
Shares of Tenet Healthcare experienced a notable increase of 7.6% in morning trading on July 3, 2026. This surge followed Cantor Fitzgerald's reiteration of an "Overweight" rating for the hospital operator's stock, accompanied by a price target of $245.00.
The positive market reaction was bolstered by survey results from Cantor Fitzgerald, which pointed to an improvement in patient acuity. This metric, reflecting the severity of patient conditions, is an area where Tenet Healthcare typically demonstrates strong performance.
These developments build upon recent successes for Tenet. The company reported robust first-quarter 2026 earnings, with earnings per share of $4.82 exceeding expectations. Furthermore, Moody's Ratings recently upgraded Tenet's credit rating, citing sustained debt reduction and consistent earnings growth.
Tenet Healthcare's stock has shown relative stability over the past year, with only eight instances of movement exceeding 5%. The current 7.6% gain is considered significant by the market. Analyst Andrew Mok maintained an "Overweight" rating, signaling continued confidence in Tenet's potential.
Year-to-date, Tenet Healthcare has risen 2.7%. However, its current trading price of $204.79 per share is still 16.3% below its 52-week high of $244.80, reached in March 2026. An investment of $1,000 in Tenet Healthcare five years ago would now be valued at $2,988.
